Delivery Order SPE2DB20D3104-SPE2DB25FW0M6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and up) in 0.5ML syringes, with a ceiling value of $1,177.48 and completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction reflecting the agency's procurement of influenza vaccines to support military healthcare operations. The order was placed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,431.78 on June 18, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and older) in 0.5 mL syringes. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and up) in 0.5mL syringes, with a contract ceiling value of $7,158.90 and a completion date of July 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract...
- The Defense Logistics Agency awarded a $1,177.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2024-25 vaccine (12 years and up) in 0.5ml syringes, with an ultimate completion date of October 3, 2025. This is a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,168.19 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine doses (12 years and older, 0.5ml syringes), with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child order under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $6,512.80 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Spikevax 2025-26 vaccine (6 months to 11 years) in 0.25 mL syringes. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 26, 2025. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $8,672.76 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (0.5mL syringes for ages 12 and up) on September 15, 2025, with completion expected by October 6, 2025. This firm fixed-price, non-set-aside contract represents a discrete purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be supplied from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and older) in 0.5 mL syringes, valued at $7,227.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 20, 2025, with performance based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,613.65 to supply Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes, with an ultimate completion date of October 20, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The point of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for $7,227.30 to supply Spikevax 2025-26 vaccine (12 years and older) in 0.5 mL syringes. This is a firm fixed price delivery order with no set-aside designation, reflecting open competitive procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. As a child contract, this delivery...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FW0M6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,302.58 to supply Spikevax 2025-26 vaccine (6M-11Y) in 0.25ML syringes, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds significant federal contracts for medical procurement across military and veteran healthcare systems. The company's federal contracting portfolio demonstrates extensive experience fulfilling diverse pharmaceutical and medical supply requirements through the DLA, including vaccines, specialty medications, brand-name and generic drugs, and medical devices. This vaccine delivery order reflects AmerisourceBergen's critical role in supporting Department of Defense immunization programs and the broader federal healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/26/25 |